by John Cook on Aug 14, 2026 at 8:46 am August 14, 2026 at 8:50 am
A bio-manufacturing facility in Everett that was built by Seattle biotech giant Seagen but never opened under its Pfizer ownership is getting a new lease on life.
Breakthrough Properties, a life sciences real estate company, said Friday that it has acquired the 270,000-square-foot facility at 215 Shuksan Way for $78 million and leased the entire campus for 21 years to an unnamed global biopharmaceutical company.
Seagen invested approximately $350 million to build out the facility, which was designed for drug manufacturing, quality-control labs, warehousing and distribution. But…
Read the full article at GEEKWIRE.COM


